Psilocybe mushrooms, psilocybin & psilocin
See all (314)
Meldrum & Naquet (1971). Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio). Electroencephalography & Clinical Neurophysiology.
Tilson, Marquis & Rech (1973). The effects of d-amphetamine, 2,5-dimethoxy-4-methyl-amphetamine (DOM), and psilocybin on fixed-interval responding in the rat. Proceedings of the Annual Convention of the American Psychological Association.
Ladefoged (1974). The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits. Archives Internationales de Pharmacodynamie et de Therapie.
Beug & Bigwood (1981). Quantitative analysis of psilocybin and psilocin in psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography. Journal of Chromatography.
Vanhaelen-Fastré & Vanhaelen (1984). Qualitative and quantitative determinations of hallucinogenic components of psilocybe mushrooms by reversed-phase high-performance liquid chromatography. Journal of Chromatography.
Musha et al. (1988). [Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning]. Seishin Shinkeigaku Zasshi.
Gartz, Allen & Merlin (1994). Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand. Journal of Ethnopharmacology.
Hasler et al. (1997). Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharmaceutica Acta Helvetiae.
Gouzoulis-Mayfrank (1999). Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology.
Gouzoulis-Mayfrank (1999). Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. Psychopharmacology.
Umbricht et al. (2003). Effects of the 5-HT 2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: Implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology.
Anastos et al. (2005). Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection respectively. Talanta.
Kamata et al. (2005). Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples. Journal of Forensic Sciences.
Anastos et al. (2006). The determination of psilocin and psilocybin in hallucinogenic mushrooms by HPLC utilizing a dual reagent acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection system. Journal of Forensic Sciences.
Vollenweider et al. (2007). The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Neuropsychopharmacology.
Riley, Thompson & Griffin (2010). Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds. The International Journal on Drug Policy.
Carhart-Harris et al. (2011). The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: A preliminary investigation of tolerability. Journal of Psychopharmacology.
Kometer et al. (2012). Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biological Psychiatry.
Kometer et al. (2013). Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. The Journal of Neuroscience.
Young (2013). Single treatments that have lasting effects: Some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Journal of Psychiatry & Neuroscience.
Dos Santos et al. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology.
Gambaro et al. (2016). DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin. Journal of Pharmaceutical and Biomedical Analysis.
Griffiths et al. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology.
Ross et al. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology.
Bravermanová et al. (2018). Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—Study on P300 and mismatch negativity in healthy volunteers. Psychopharmacology.
Carrillo et al. (2018). Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. Journal of Affective Disorders.
Griffiths et al. (2018). Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology.